Search the GHTC website
February 11, 2018

GHTC statement on the President’s FY 2019 budget

The United States has long led the world in developing vaccines, drugs, diagnostics, and other technologies for neglected diseases and conditions that affect the world’s most vulnerable people, and the President’s budget proposal threatens to undermine this scientific and humanitarian legacy.

January 18, 2018

GHTC welcomes House passage of the Global Health Innovation Act

GHTC welcomes yesterday’s passage by the US House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the US Agency for International Development (USAID) to develop lifesaving drugs, vaccines, and other health technologies for people in need around the world.

November 29, 2017

GHTC honors Senator Coons, Congressman Cole, and the dapivirine microbicide ring with Innovating for Impact Awards

Esteemed leaders from across the US government, industry, and the global health and medical research communities gathered at the Newseum in Washington, DC yesterday for GHTC’s Innovating for Impact Awards to celebrate US commitment to global health R&D and recognize Senator Chris Coons (D-DE) and Congressman Tom Cole (R-OK) for their congressional leadership on this issue. GHTC also honored the partnership that developed the dapivirine microbicide ring—a woman-centered HIV prevention tool—for its efforts to advance this groundbreaking new technology.

August 27, 2017

GHTC launches call for nominations for Innovating for Impact Awards

GHTC's new Innovating for Impact Awards initiative will celebrate the often under-recognized partnerships and political champions that drive global health R&D. The nomination deadline is September 20, 2017.